Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2015 | 07-2014 | 07-2013 | 07-2012 | 07-2011 | |
| Sales | 729 | 550 | 820 | 812 | 464 |
| Cost of Goods | 285 | 344 | 565 | 264 | 131 |
| Gross Profit | 444 | 206 | 255 | 548 | 333 |
| Operating Expenses | 8,369 | 12,452 | 8,159 | 9,566 | 8,831 |
| Operating Income | -7,640 | -11,902 | -7,339 | -8,754 | -8,367 |
| Interest Expense | 8 | 10 | 593 | 144 | 0 |
| Other Income | 21 | 862 | 261 | 8 | 18 |
| Pre-tax Income | -7,627 | -11,050 | -7,671 | -8,890 | -8,349 |
| Net Income Continuous | -7,627 | -11,050 | -7,671 | -8,890 | -8,349 |
| Net Income | $-7,627 | $-11,050 | $-7,671 | $-8,890 | $-8,349 |
| EPS Basic Total Ops | -0.19 | -0.43 | -0.71 | -1.58 | -1.79 |
| EPS Basic Continuous Ops | -0.19 | -0.43 | -0.71 | -1.58 | -1.79 |
| EPS Diluted Total Ops | -0.19 | -0.43 | -0.71 | -1.58 | -1.79 |
| EPS Diluted Continuous Ops | -0.19 | -0.43 | -0.71 | -1.58 | -1.79 |
| EBITDA(a) | $-7,319 | $-10,975 | $-6,187 | $-7,811 | $-7,896 |